Payment overview · 2025
General Payments
$94.51
4 reported records · 3 companies
Healthcare provider profile · identity verified
Robert C Hernandez, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SHREVEPORT, LA · NPI 1043247745
Verified facts
What the public records show
CMS Open Payments records show Robert C Hernandez, MD received $94.51 in general payments during 2025 across 4 reported records.
Neurocrine BioSciences, Inc. accounted for 59.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Nuedexta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $56.41 | 59.7% | 2 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $21.83 | 23.1% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $16.27 | 17.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $94.51 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $56.41 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $38.10 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 818 | 162 |
| Levothyroxine Sodium | Levothyroxine Sodium | 605 | 106 |
| Amlodipine Besylate | Amlodipine Besylate | 530 | 108 |
| Eliquis | Apixaban | 529 | 56 |
| Furosemide | Furosemide | 527 | 86 |
| Potassium Chloride | Potassium Chloride | 515 | 84 |
| Sertraline Hcl | Sertraline Hcl | 509 | 76 |
| Pantoprazole Sodium | Pantoprazole Sodium | 497 | 99 |
| Trazodone Hcl | Trazodone Hcl | 425 | 76 |
| Lisinopril | Lisinopril | 388 | 56 |
| Losartan Potassium | Losartan Potassium | 377 | 87 |
| Gabapentin | Gabapentin | 343 | 58 |
| Divalproex Sodium | Divalproex Sodium | 316 | 40 |
| Donepezil Hcl | Donepezil Hcl | 303 | 45 |
| Duloxetine Hcl | Duloxetine Hcl | 295 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 285 | 60 |
| Clopidogrel | Clopidogrel Bisulfate | 251 | 32 |
| Metoprolol Tartrate | Metoprolol Tartrate | 250 | 53 |
| Memantine Hcl | Memantine Hcl | 238 | 40 |
| Quetiapine Fumarate | Quetiapine Fumarate | 235 | 44 |
| Carvedilol | Carvedilol | 215 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 209 | 44 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 206 | 43 |
| Famotidine | Famotidine | 182 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 181 | 39 |
| Metformin Hcl | Metformin Hcl | 175 | 37 |
| Omeprazole | Omeprazole | 164 | 35 |
| Buspirone Hcl | Buspirone Hcl | 157 | 33 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 148 | 21 |
| Montelukast Sodium | Montelukast Sodium | 146 | 25 |
| Meloxicam | Meloxicam | 145 | 27 |
| Levetiracetam | Levetiracetam | 140 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 137 | 23 |
| Mirtazapine | Mirtazapine | 134 | 27 |
| Escitalopram Oxalate | Escitalopram Oxalate | 124 | 27 |
| Metformin Hcl Er | Metformin Hcl | 116 | 21 |
| Nifedipine Er | Nifedipine | 116 | 19 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 115 | 23 |
| Januvia | Sitagliptin Phosphate | 114 | suppressed |
| Allopurinol | Allopurinol | 107 | 19 |
| Pravastatin Sodium | Pravastatin Sodium | 103 | 24 |
| Risperidone | Risperidone | 100 | 12 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 98 | 32 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 96 | 12 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 92 | 32 |
| Simvastatin | Simvastatin | 92 | 35 |
| Tresiba Flextouch U-100 | Insulin Degludec | 88 | 16 |
| Xarelto | Rivaroxaban | 87 | 15 |
| Myrbetriq | Mirabegron | 86 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 80 | 26 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 78 | 17 |
| Prednisone | Prednisone | 78 | 29 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 76 | 14 |
| Alendronate Sodium | Alendronate Sodium | 73 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 72 | 24 |
| Ezetimibe | Ezetimibe | 70 | 15 |
| Tramadol Hcl | Tramadol Hcl | 70 | 31 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 65 | suppressed |
| Jardiance | Empagliflozin | 65 | 14 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 65 | 34 |
| Atenolol | Atenolol | 64 | suppressed |
| Primidone | Primidone | 64 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 64 | suppressed |
| Spironolactone | Spironolactone | 64 | 11 |
| Alprazolam | Alprazolam | 63 | 27 |
| Finasteride | Finasteride | 62 | 13 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 60 | 15 |
| Baclofen | Baclofen | 59 | suppressed |
| Aripiprazole | Aripiprazole | 58 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 56 | 13 |
| Trulicity | Dulaglutide | 56 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 54 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 54 | suppressed |
| Bumetanide | Bumetanide | 53 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 50 | 14 |
| Linzess | Linaclotide | 50 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 49 | 37 |
| Nystatin | Nystatin | 49 | 23 |
| Gemtesa | Vibegron | 48 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 48 | 17 |
| Lorazepam | Lorazepam | 47 | 13 |
| Latanoprost | Latanoprost | 46 | 12 |
| Oxybutynin Chloride | Oxybutynin Chloride | 46 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 45 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 44 | 36 |
| Clonazepam | Clonazepam | 43 | 13 |
| Fluconazole | Fluconazole | 43 | 27 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 43 | 12 |
| Valsartan | Valsartan | 43 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 42 | 23 |
| Doxycycline Hyclate | Doxycycline Hyclate | 42 | 33 |
| Methocarbamol | Methocarbamol | 42 | 15 |
| Clonidine | Clonidine | 41 | suppressed |
| Entresto | Sacubitril/Valsartan | 41 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 41 | suppressed |
| Topiramate | Topiramate | 41 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 39 | 15 |
| Ozempic | Semaglutide | 39 | suppressed |
| Glipizide | Glipizide | 37 | suppressed |
| Levofloxacin | Levofloxacin | 37 | 23 |
| Ondansetron Odt | Ondansetron | 37 | 24 |
| Divalproex Sodium Er | Divalproex Sodium | 36 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 35 | suppressed |
| Bupropion Xl | Bupropion Hcl | 34 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 33 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 32 | suppressed |
| Celecoxib | Celecoxib | 32 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 32 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 32 | 25 |
| Glucagon Emergency Kit | Glucagon | 31 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 31 | suppressed |
| Calcitriol | Calcitriol | 30 | suppressed |
| Ramipril | Ramipril | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 29 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 29 | suppressed |
| Olanzapine | Olanzapine | 29 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 29 | 11 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 28 | suppressed |
| Digoxin | Digoxin | 28 | suppressed |
| Novolog Flexpen | Insulin Aspart | 28 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 27 | 23 |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 27 | 17 |
| Propafenone Hcl | Propafenone Hcl | 27 | suppressed |
| Tradjenta | Linagliptin | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 14 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 26 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 26 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Cilostazol | Cilostazol | 25 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 25 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 25 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 25 | 12 |
| Klor-Con 10 | Potassium Chloride | 25 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 25 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 25 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 21 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 23 | 13 |
| Rivastigmine | Rivastigmine | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 22 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 22 | suppressed |
| Estradiol | Estradiol | 22 | suppressed |
| Glimepiride | Glimepiride | 22 | 13 |
| Lidocaine | Lidocaine | 22 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 22 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | suppressed |
| Cephalexin | Cephalexin | 21 | 12 |
| Invega Sustenna | Paliperidone Palmitate | 21 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 21 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 21 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 21 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Invokana | Canagliflozin | 20 | suppressed |
| Irbesartan | Irbesartan | 20 | suppressed |
| Lacosamide | Lacosamide | 20 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 20 | suppressed |
| Vascepa | Icosapent Ethyl | 20 | suppressed |
| Zonisamide | Zonisamide | 20 | suppressed |
| Chlorthalidone | Chlorthalidone | 19 | suppressed |
| Lovastatin | Lovastatin | 19 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 19 | suppressed |
| Rytary | Carbidopa/Levodopa | 19 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 18 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Fentanyl | Fentanyl | 17 | suppressed |
| Lactulose | Lactulose | 17 | suppressed |
| Levocarnitine | Levocarnitine | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 16 | suppressed |
| Enulose | Lactulose | 16 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 14 |
| Trintellix | Vortioxetine Hydrobromide | 16 | suppressed |
| Brilinta | Ticagrelor | 15 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Amoxicillin | Amoxicillin | 14 | 13 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 14 | 13 |
| Chlorzoxazone | Chlorzoxazone | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 14 | 14 |
| Avonex Pen (4 Pack) | Interferon Beta-1a | 13 | suppressed |
| Buprenorphine | Buprenorphine | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 11 |
| Novolin R Flexpen | Insulin Regular, Human | 13 | suppressed |
| Paliperidone Er | Paliperidone | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Modafinil | Modafinil | 12 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 12 | suppressed |
| Novolin R | Insulin Regular, Human | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Ibuprofen | Ibuprofen | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $94.51 · 4 records | Neurocrine BioSciences, Inc. | INGREZZA, REXULTI | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error